August 31, 2016 10:24 AM ET

Biotechnology

Company Overview of Catabasis Pharmaceuticals, Inc.

Executive Profile

Kenneth M. Bate MBA

Co-Chairman, Chairman of Audit Committee and Member of Compensation Committee, Catabasis Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 15 different industries.

See Board Relationships
66$137,722

Background

Mr. Kenneth M. Bate, also known as Ken, MBA was a Principal of JSB-Partners, LP. Mr. Bate has been an independent biotechnology industry consultant since May 2009. He served as the President of Newport Acquisition Corp., a wholly owned subsidiary of NitroMed Inc. He served as the Chief Executive Officer and President of NitroMed Inc., since January 22, 2007 until 2009 and also its Interim Chief Financial Officer from April 11, 2008 to 2009. He is an experienced biotechnology ...

Corporate Headquarters

Building 1400E
Cambridge, Massachusetts 02139

United States

Phone: 617-349-1971
Fax: 617-273-2637

Board Members Memberships

Director
2007-Present
Director, Chairman of Audit Committee and Member of Compensation Committee
2014-Present
Director, Chairman of Compensation Committee and Member of Audit Committee
2014-Present
Independent Director and Member of Audit Committee
2014-Present
Co-Chairman, Chairman of Audit Committee and Member of Compensation Committee
2015-Present
Independent Director
2016-Present
Director

Education

BA
Williams College
MBA
University of Pennsylvania - The Wharton School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

Exercisable Options$4,941
Unexercisable Options$16,036
Total Number of Options$20,977

Total Compensation

Total Annual Cash Compensation$46,875
Total Calculated Compensation$137,722
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Catabasis Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.